So, the expectation of being paid in 3 years and efficiency paying off the current debt will set the price. To those ends, we now have a pipeline of money flowing from retail to us and from there to the people who will pay us in 3 yes and who we've owed money to for years. That's what started today. While CBD is a chump space, the money is real and we need money.

Still standing by for the explosive potential of a positive CDNF result. Still standing by for a successful Reg A with arbitrage. What else is lutkk g in the pipeline from the work of the past year. The New York weed Co? How many others will pay us for expertise. When will the Elto deal close? When will the Lympro trial conclude?